Pioneering research at Saint Mary’s Hospital is trialling cannabidiol (CBD) – in conjunction with the NHS standard of care – as a potential treatment for newborns with moderate or severe brain injury.
A new trial opens in Greater Manchester today which is to test cutting-edge wearable technologies involving patients who have received cancer treatment.
MFT joins a growing group of like-minded organisations working together to realise the benefits of using health data for research and innovation for public benefit.
MFT has joined global partners as part of the Smart Hospital Alliance (SHA) to drive the expansion of cutting-edge digital health technologies for the benefit of our patients and communities.
The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.